Study of AB680 in cancer patients.
Phase of Trial: Phase I
Latest Information Update: 16 May 2018
At a glance
- Drugs AB-680 (Primary)
- Indications Cancer
- Focus Adverse reactions
- 16 May 2018 New trial record
- 09 May 2018 According to the Arcus Biosciences media release, this trial is expected to begin in in the first half of 2019.